출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2022년11월
홈 헬스케어(Home Healthcare) 시장 : 제품(투석기기, IV기기, 인공호흡기, 응고 모니터, 피크 플로우 미터), 서비스(수액 요법, 전문 간호, 호스피스), 적응증(암, 상처 케어, 당뇨병), 지역별 – 2027년까지 세계 예측
Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), and Region – Global Forecast to 2027
| 페이지수 | 324 |
| 도표수 | 298 |
| 구성 | 영문조사보고서 |
| 가격 |
The global home healthcare market is projected to reach USD 340.2 Billion by 2027 from USD 226.0 Billion in 2022, at a CAGR of 8.5% during the forecast period Growth in this market is mainly driven by the technological advancements in home healthcare products and services.
세계 홈 헬스케어 시장은 2022년 2,260억 달러에서 2027년까지 3,402억 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 8.5% 성장할 것입니다. 이 시장의 성장은 주로 홈 헬스케어 제품 및 서비스의 기술 발전에 의해 주도됩니다.
“The therapeutic products segment accounted for the highest growth rate in the home healthcare market, by product, during the forecast period.”
The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products based on product. In 2021, the therapeutic products segment accounted for the highest growth rate in the home healthcare market. Market growth can largely be attributed to growing prevalence of chronic diseases.
“Infusion therapy services segment accounted for the highest CAGR.”
Based on the services, the home healthcare market has been segmented into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. In 2021, the skilled nursing services segment accounted for the highest growth rate. This can be attributed to the rising population and urbanization.
“Asia Pacific: The fastest-growing region home healthcare market.”
The global home healthcare market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as initiatives by government to promote home healthcare, and higher healthcare costs.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:
• Fresenius SE & Co. KGaA (Germany)
• Linde, Plc (Ireland)
• F.Hoffmann-La Roche, Ltd. (Switzerland)
• A&D Company, Limited (Japan)
• Bayada Home Health Care (US)
• Invacare Corporation (US)
• Abbott (US)
• Amedisys (US)
• ResMed, Inc. (US)
• LHC Group, Inc. (US)
• Omron Corporation (Japan)
• Koninkluke Philips N.V. (Netherlands)
• GE Healthcare (US)
• Drive Devilbiss Healthcare (UK)
• Hamilton Medical (Switzerland)
• Sunrise Medical (Germany)
• Roma Medical (UK)
• Caremax Rehabilitation Equipment Co., Ltd. (China)
• Vitalograph (UK)
• Advita Pflegedienst Gmbh (Germany)
• Renafan Gmbh (Germany)
• ADMR (France)
• Apex Medical Corp. (Taiwan)
• Contec Medical Systems Co., Ltd. (China)
• Löwenstein Medical Technology Gmbh + Co., KG. (Germany)
• B. Braun Melsungen Ag (Germany)
• Baxter International, Inc. (US)
• Allied Healthcare Products, Inc. (US)
• Medline Industries, Inc. (US)
• Advin Health Care (India)
Research Coverage:
This report provides a detailed picture of the global home healthcare market. It aims at estimating the size and future growth potential of the market across different segments, such as product, service, indication, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall home healthcare market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
목차
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
TABLE 1 INCLUSIONS AND EXCLUSIONS 34
1.3 STUDY SCOPE 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 37
1.8 LIMITATIONS 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY 39
2.1.1 SECONDARY DATA 39
2.1.1.1 Secondary sources 41
2.1.2 PRIMARY DATA 41
TABLE 2 KEY DATA FROM PRIMARY SOURCES 42
FIGURE 2 KEY INDUSTRY INSIGHTS 43
2.1.2.1 Breakdown of primary interviews 43
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE MARKET) 43
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 44
2.2 MARKET SIZE ESTIMATION 44
2.2.1 BOTTOM-UP APPROACH 45
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 45
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD. 46
2.2.1.1 Growth forecast 46
2.2.1.2 CAGR projections 47
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
2.2.2 TOP-DOWN APPROACH 47
FIGURE 8 HOME HEALTHCARE MARKET: TOP-DOWN APPROACH 47
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 48
2.4 MARKET SHARE ANALYSIS 49
2.5 STUDY ASSUMPTIONS 49
2.6 RISK ASSESSMENT 49
3 EXECUTIVE SUMMARY 50
FIGURE 10 HOME HEALTHCARE MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 50
FIGURE 11 HOME HEALTHCARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION) 51
FIGURE 12 HOME HEALTHCARE MARKET, BY SERVICE, 2022 VS. 2027 (USD BILLION) 51
FIGURE 13 HOME HEALTHCARE MARKET, BY INDICATION, 2022 VS. 2027 (USD BILLION) 52
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF HOME HEALTHCARE MARKET 53
4 PREMIUM INSIGHTS 54
4.1 HOME HEALTHCARE MARKET OVERVIEW 54
FIGURE 15 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 54
4.2 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT (2021) 55
FIGURE 16 THERAPEUTIC PRODUCTS ACCOUNTED FOR LARGEST MARKET SHARE 55
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES IN HOME HEALTHCARE MARKET 56
FIGURE 17 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 56
4.4 HOME HEALTHCARE MARKET: GEOGRAPHIC MIX 56
FIGURE 18 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 56
4.5 HOME HEALTHCARE MARKET: DEVELOPED VS. EMERGING ECONOMIES 57
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 20 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.2.1 DRIVERS 59
5.2.1.1 Rapid growth in elderly population and rising incidence of chronic diseases 59
TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION) 59
5.2.1.2 Rising R&D investments 60
TABLE 4 PRODUCT LAUNCHES 60
5.2.1.3 Growing need for cost-effective healthcare delivery due to rising costs 61
5.2.1.4 Increased preference for personalized care 61
5.2.2 RESTRAINTS 61
5.2.2.1 Changing reimbursement policies 61
5.2.2.2 Limited insurance coverage 62
5.2.2.3 Patient safety concerns 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 Rising focus on telehealth 63
5.2.3.2 Untapped developing regions 64
5.2.3.3 Growing demand for home-use therapeutic devices 64
5.2.3.4 Growing demand for home sleep apnea tests 65
5.2.3.5 Rising preference for home hemodialysis treatment 66
5.2.4 CHALLENGES 66
5.2.4.1 Shortage of home care workers 66
5.2.4.2 Lack of supporting infrastructure 67
5.3 PRICING ANALYSIS 68
TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2022) 68
TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS (2022) 68
5.4 PATENT ANALYSIS 72
5.4.1 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES 72
5.4.1.1 Granted patent publication trends for temperature monitoring devices 72
FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2021) 72
5.4.1.2 Insights: Jurisdiction and top applicant analysis 73
FIGURE 22 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR TEMPERATURE MONITORING DEVICES (JANUARY 2012–DECEMBER 2021) 73
FIGURE 23 TOP PATENT APPLICANT COUNTRIES/REGIONS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2012–DECEMBER 2021) 74
FIGURE 24 PATENT ANALYSIS FOR THERMOMETERS (JANUARY 2012–DECEMBER 2021) 74
5.4.2 LIST OF KEY PATENTS 75
5.5 VALUE CHAIN ANALYSIS 76
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 76
5.6 SUPPLY CHAIN ANALYSIS 77
FIGURE 26 HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS 78
5.7 ECOSYSTEM/MARKET MAP 78
FIGURE 27 HOME HEALTHCARE MARKET: ECOSYSTEM/MARKET MAP 79
5.7.1 HOME HEALTHCARE MARKET: ROLE IN ECOSYSTEM 79
5.8 PORTER’S FIVE FORCES ANALYSIS 80
5.8.1 PULSE OXIMETERS 80
TABLE 7 PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET 80
5.8.1.1 Threat of new entrants 80
5.8.1.2 Threat of substitutes 81
5.8.1.3 Bargaining power of suppliers 81
5.8.1.4 Bargaining power of buyers 81
5.8.1.5 Degree of competition 81
5.8.2 HEARING AIDS 82
TABLE 8 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET 82
5.8.2.1 Threat of new entrants 82
5.8.2.2 Threat of substitutes 82
5.8.2.3 Bargaining power of buyers 82
5.8.2.4 Bargaining power of suppliers 82
5.8.2.5 Degree of competition 82
5.9 REGULATORY LANDSCAPE 83
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 13 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
5.9.1 NORTH AMERICA 85
5.9.1.1 US 85
TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES 85
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 86
FIGURE 28 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 86
5.9.1.2 Canada 86
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 86
FIGURE 29 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA 87
5.9.2 EUROPE 87
FIGURE 30 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES 88
5.9.3 ASIA PACIFIC 88
5.9.3.1 Japan 88
TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 89
5.9.3.2 China 89
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 90
5.9.3.3 India 91
5.10 TRADE ANALYSIS 92
5.10.1 TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS 92
TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY,
2017–2021 (USD MILLION) 92
TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY,
2017–2021 (USD MILLION) 92
5.11 TECHNOLOGY ANALYSIS 93
5.12 KEY CONFERENCES & EVENTS IN 2022–2023 94
TABLE 21 HOME HEALTHCARE MARKET: CONFERENCES & EVENTS 94
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
FIGURE 31 REVENUE SHIFT IN HOME HEALTHCARE 95
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS 96
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS 96
5.14.2 BUYING CRITERIA 97
FIGURE 33 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS 97
TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS 97
6 HOME HEALTHCARE MARKET, BY PRODUCT 98
6.1 INTRODUCTION 99
TABLE 24 HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD BILLION) 99
6.2 THERAPEUTIC PRODUCTS 100
TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED 100
TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD BILLION) 101
TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2020–2027 (USD BILLION) 101
6.2.1 DIALYSIS EQUIPMENT 102
6.2.1.1 Dialysis equipment to hold largest market share 102
TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 103
6.2.2 WOUND CARE PRODUCTS 103
6.2.2.1 Decreased costs and higher convenience and comfort to drive market growth 103
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION) 104
6.2.3 IV EQUIPMENT 104
6.2.3.1 Accuracy and growing target disease prevalence to ensure market growth 104
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 105
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES 105
6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market 105
TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 106
6.2.5 INSULIN DELIVERY DEVICES 106
6.2.5.1 High incidence of diabetes to drive market 106
TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 106
6.2.6 OXYGEN DELIVERY SYSTEMS 107
6.2.6.1 Technological advancements in oxygen therapy products to drive market 107
TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2020–2027 (USD MILLION) 107
6.2.7 INHALERS 107
6.2.7.1 High incidence of asthma to boost market 107
TABLE 34 INHALERS MARKET, BY REGION, 2020–2027 (USD MILLION) 108
6.2.8 NEBULIZERS 108
6.2.8.1 Effectiveness over oral dosages to push preference for nebulizers 108
TABLE 35 NEBULIZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 109
6.2.9 VENTILATORS 109
6.2.9.1 Convenience and comfort to sustain end-user preference 109
TABLE 36 VENTILATORS MARKET, BY REGION, 2020–2027 (USD MILLION) 110
6.2.10 OTHER THERAPEUTIC PRODUCTS 110
TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 110
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS 111
TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED 111
TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION) 113
6.3.1 BLOOD GLUCOSE MONITORS 113
6.3.1.1 Increasing prevalence of diabetes to drive market growth 113
TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2020–2027 (USD MILLION) 114
6.3.2 HEARING AIDS 114
6.3.2.1 High incidence of hearing impairment to drive market 114
TABLE 42 HEARING AIDS MARKET, BY REGION, 2020–2027 (USD MILLION) 115
6.3.3 ACTIVITY MONITORS & WRISTBANDS 115
6.3.3.1 Increasing prevalence of chronic diseases to bolster demand for activity monitors 115
TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2020–2027 (USD MILLION) 115
6.3.4 BLOOD PRESSURE MONITORS 116
6.3.4.1 Rising patient population for hypertension and CVD to drive market 116
TABLE 44 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2020–2027 (USD MILLION) 116
6.3.5 ECG/EKG DEVICES 117
6.3.5.1 High prevalence of CVD to support demand 117
TABLE 45 ECG/EKG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 117
6.3.6 TEMPERATURE MONITORING DEVICES 118
6.3.6.1 Technological innovations and increasing awareness to drive growth 118
TABLE 46 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 118
6.3.7 HEART RATE MONITORS 119
6.3.7.1 Continuous cardiac parameter monitoring capabilities to drive demand 119
TABLE 47 HEART RATE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 119
6.3.8 OVULATION & PREGNANCY TEST KITS 119
6.3.8.1 Privacy, convenience, accessibility, and quick results to drive market 119
TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION,
2020–2027 (USD MILLION) 120
6.3.9 FETAL MONITORING DEVICES 120
6.3.9.1 Remote-based care by portable fetal monitoring systems to drive market growth 120
TABLE 49 FETAL MONITORING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 121
6.3.10 PULSE OXIMETERS 121
6.3.10.1 Rising disease incidence and wide usage of pulse oximetry to ensure strong demand 121
TABLE 50 PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 122
6.3.11 HIV TEST KITS 122
6.3.11.1 Rising prevalence of HIV to drive market 122
TABLE 51 HIV TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION) 122
6.3.12 HOLTER & EVENT MONITORS 123
6.3.12.1 Rising awareness of preventive care and technological advancements to drive market 123
TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION,
2020–2027 (USD MILLION) 123
6.3.13 DRUG & ALCOHOL TEST KITS 123
6.3.13.1 Rising consumption of drugs among teens to support market growth 123
TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION,
2020–2027 (USD MILLION) 124
6.3.14 COAGULATION MONITORING PRODUCTS 124
6.3.14.1 Rising use of anticoagulant therapy and availability of home-use kits to drive market 124
TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION) 125
6.3.15 PEAK FLOW METERS 125
6.3.15.1 High portability and cost-efficiency to ensure adoption 125
TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION) 126
6.3.16 COLON CANCER TEST KITS 126
6.3.16.1 High incidence of colorectal cancer to drive market growth 126
TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION) 126
6.3.17 HOME SLEEP TESTING DEVICES 127
6.3.17.1 Cost-effectiveness of home-based sleep tests to fuel growth 127
TABLE 57 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 128
6.3.18 EEG DEVICES 128
6.3.18.1 Wide patient population for epilepsy to drive market for EEG devices 128
TABLE 58 EEG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 128
6.3.19 CHOLESTEROL TESTING PRODUCTS 129
6.3.19.1 Rising obesity levels and CVD incidence to support market 129
TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION) 129
6.3.20 HOME HEMOGLOBIN A1C TEST KITS 129
6.3.20.1 High incidence of diabetes to drive market 129
TABLE 60 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2020–2027 (USD MILLION) 130
6.4 MOBILITY CARE PRODUCTS 130
TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET 130
TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION) 132
6.4.1 WHEELCHAIRS 132
6.4.1.1 Increased preference for wheelchairs to boost demand 132
TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2020–2027 (USD MILLION) 133
6.4.2 MOBILITY SCOOTERS 133
6.4.2.1 High cost to affect end-user adoption 133
TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 133
6.4.3 WALKERS & ROLLATORS 134
6.4.3.1 Difficulties in using walkers and availability of alternatives to restrain market 134
TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2020–2027 (USD MILLION) 134
6.4.4 CRUTCHES 134
6.4.4.1 High preference for axilla crutches to support demand 134
TABLE 67 CRUTCHES MARKET, BY REGION, 2020–2027 (USD MILLION) 135
6.4.5 CANES 135
6.4.5.1 Wide usage of canes to drive market 135
TABLE 68 CANES MARKET, BY REGION, 2020–2027 (USD MILLION) 135
7 HOME HEALTHCARE MARKET, BY SERVICE 136
7.1 INTRODUCTION 137
TABLE 69 HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD BILLION) 137
TABLE 70 HOME HEALTHCARE SERVICES MARKET, BY REGION,
2020–2027 (USD BILLION) 137
7.2 SKILLED NURSING SERVICES 138
7.2.1 SKILLED NURSING SERVICES TO DOMINATE MARKET 138
TABLE 71 SKILLED NURSING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 138
7.3 REHABILITATION THERAPY SERVICES 138
7.3.1 RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND FOR THERAPY 138
TABLE 72 REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 139
7.4 HOSPICE & PALLIATIVE CARE SERVICES 139
7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICE DEMAND 139
TABLE 73 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 140
7.5 UNSKILLED CARE SERVICES 140
7.5.1 COST-EFFECTIVENESS TO DRIVE GROWTH 140
TABLE 74 UNSKILLED SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 141
7.6 RESPIRATORY THERAPY SERVICES 141
7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET 141
TABLE 75 RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 142
7.7 INFUSION THERAPY SERVICES 142
7.7.1 SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND 142
TABLE 76 INFUSION THERAPY SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 143
7.8 PREGNANCY CARE SERVICES 143
7.8.1 NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH 143
TABLE 77 PREGNANCY CARE MARKET, BY REGION, 2020–2027 (USD MILLION) 144
8 HOME HEALTHCARE MARKET, BY INDICATION 145
8.1 INTRODUCTION 146
TABLE 78 HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD BILLION) 146
TABLE 79 HOME HEALTHCARE INDICATIONS MARKET, BY REGION,
2020–2027 (USD BILLION) 146
8.2 CANCER 147
8.2.1 CANCER TO DOMINATE INDICATIONS MARKET 147
TABLE 80 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 147
TABLE 81 HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2020–2027 (USD MILLION) 148
8.3 RESPIRATORY DISEASES 148
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 148
TABLE 82 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2020–2027 (USD MILLION) 149
8.4 MOVEMENT DISORDERS 149
8.4.1 GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT 149
TABLE 83 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2020–2027 (USD MILLION) 150
8.5 CVD & HYPERTENSION 150
8.5.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH 150
TABLE 84 HOME HEALTHCARE MARKET FOR CVD & HYPERTENSION, BY REGION,
2020–2027 (USD MILLION) 151
8.6 PREGNANCY 151
8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH 151
TABLE 85 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2020–2027 (USD MILLION) 152
8.7 WOUND CARE 152
8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH 152
TABLE 86 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2020–2027 (USD MILLION) 153
8.8 DIABETES 153
8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH 153
TABLE 87 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2020–2027 (USD MILLION) 154
8.9 HEARING DISORDERS 154
8.9.1 WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH 154
TABLE 88 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION,
2020–2027 (USD MILLION) 154
8.10 OTHER INDICATIONS 155
TABLE 89 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2020–2027 (USD MILLION) 155
9 HOME HEALTHCARE MARKET, BY REGION 156
9.1 INTRODUCTION 157
TABLE 90 HOME HEALTHCARE MARKET, BY REGION, 2020–2027 (USD BILLION) 157
9.2 NORTH AMERICA 158
FIGURE 34 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT 158
TABLE 91 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2020–2027 (USD BILLION) 159
TABLE 92 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 159
TABLE 93 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 159
TABLE 94 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 160
TABLE 95 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 96 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 162
TABLE 97 NORTH AMERICA: HOME HEALTHCARE MARKET, BY SERVICE,
2020–2027 (USD MILLION) 162
TABLE 98 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2020–2027 (USD MILLION) 163
9.2.1 US 163
9.2.1.1 US to dominate North American home healthcare market 163
TABLE 99 US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD BILLION) 164
TABLE 100 US: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 101 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 102 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 103 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 104 US: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 167
TABLE 105 US: HOME HEALTHCARE MARKET, BY INDICATION,
2020–2027 (USD MILLION) 168
9.2.2 CANADA 168
9.2.2.1 Rising geriatric population to drive market growth 168
TABLE 106 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 169
TABLE 107 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 169
TABLE 108 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 109 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 110 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 111 CANADA: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 172
TABLE 112 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 173
9.3 EUROPE 173
TABLE 113 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 174
TABLE 114 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 174
TABLE 115 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 116 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 117 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 118 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 119 EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 177
TABLE 120 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 178
9.3.1 GERMANY 178
9.3.1.1 Germany to retain market leadership in Europe 178
TABLE 121 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 179
TABLE 122 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 179
TABLE 123 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 124 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 125 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 126 GERMANY: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 182
TABLE 127 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 183
9.3.2 UK 183
9.3.2.1 Rising burden of chronic diseases to boost market growth 183
TABLE 128 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 184
TABLE 129 UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 184
TABLE 130 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 131 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 132 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 133 UK: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 187
TABLE 134 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 188
9.3.3 FRANCE 188
9.3.3.1 Government support and initiatives taken by market players to boost market 188
TABLE 135 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 189
TABLE 136 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 189
TABLE 137 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 138 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 139 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 140 FRANCE: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 192
TABLE 141 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 193
9.3.4 ITALY 193
9.3.4.1 Rising geriatric population and favorable government policy to drive market growth 193
TABLE 142 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 194
TABLE 143 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 194
TABLE 144 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 145 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 146 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 147 ITALY: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 197
TABLE 148 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 198
9.3.5 SPAIN 198
9.3.5.1 Rising geriatric population and incidence of chronic conditions to drive market growth 198
TABLE 149 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 199
TABLE 150 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 199
TABLE 151 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 152 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 153 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 154 SPAIN: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 202
TABLE 155 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 203
9.3.6 REST OF EUROPE 203
TABLE 156 ROE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 204
TABLE 157 ROE: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 204
TABLE 158 ROE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 159 ROE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 160 ROE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 161 ROE: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 207
TABLE 162 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 208
9.4 ASIA PACIFIC 208
FIGURE 35 APAC: HOME HEALTHCARE MARKET SNAPSHOT 209
TABLE 163 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 210
TABLE 164 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 210
TABLE 165 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 210
TABLE 166 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 167 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 168 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 169 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 213
TABLE 170 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 214
9.4.1 JAPAN 214
9.4.1.1 Japan to command largest share of APAC market 214
TABLE 171 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 215
TABLE 172 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 215
TABLE 173 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 174 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 175 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 176 JAPAN: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 218
TABLE 177 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 219
9.4.2 CHINA 219
9.4.2.1 Healthcare development and reforms to drive market growth 219
TABLE 178 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 220
TABLE 179 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 220
TABLE 180 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 181 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 182 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 223
TABLE 183 CHINA: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 223
TABLE 184 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 224
9.4.3 INDIA 224
9.4.3.1 Increasing target patient population to drive market 224
TABLE 185 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 225
TABLE 186 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 225
TABLE 187 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 188 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 227
TABLE 189 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 228
TABLE 190 INDIA: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 228
TABLE 191 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 229
9.4.4 REST OF ASIA PACIFIC 229
TABLE 192 ROAPAC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 230
TABLE 193 ROAPAC: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 230
TABLE 194 ROAPAC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 195 ROAPAC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 196 ROAPAC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 197 ROAPAC: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 233
TABLE 198 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 234
9.5 REST OF THE WORLD 234
TABLE 199 ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION) 235
TABLE 200 ROW: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 236
TABLE 201 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 202 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 203 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 204 ROW: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION) 238
TABLE 205 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION) 239
10 COMPETITIVE LANDSCAPE 240
10.1 OVERVIEW 240
10.2 KEY STRATEGIES ADOPTED BY PLAYERS/RIGHT TO WIN 240
TABLE 206 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 240
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 241
FIGURE 36 REVENUE SHARE ANALYSIS OF TOP PLAYERS 241
10.4 MARKET SHARE ANALYSIS 242
FIGURE 37 SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE ANALYSIS,
BY KEY PLAYER (2021) 242
FIGURE 38 BLOOD GLUCOSE MONITORS MARKET SHARE ANALYSIS,
BY KEY PLAYER (2021) 243
10.5 COMPANY EVALUATION QUADRANT (2021) 244
10.5.1 STARS 244
10.5.2 EMERGING LEADERS 244
10.5.3 PERVASIVE PLAYERS 244
10.5.4 PARTICIPANTS 244
FIGURE 39 HOME HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT, 2021 245
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 246
10.6.1 PROGRESSIVE COMPANIES 246
10.6.2 STARTING BLOCKS 246
10.6.3 RESPONSIVE COMPANIES 246
10.6.4 DYNAMIC COMPANIES 246
FIGURE 40 HOME HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 247
10.7 COMPETITIVE BENCHMARKING 248
FIGURE 41 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS 248
TABLE 207 HOME HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 248
TABLE 208 PRODUCT FOOTPRINT OF KEY PLAYERS 249
TABLE 209 REGIONAL FOOTPRINT OF KEY PLAYERS 249
TABLE 210 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES 250
10.8 COMPETITIVE SCENARIO 251
10.8.1 PRODUCT LAUNCHES 251
TABLE 211 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS 251
10.8.2 DEALS 252
TABLE 212 KEY DEALS 252
10.8.3 OTHER DEVELOPMENTS 252
TABLE 213 OTHER KEY DEVELOPMENTS, JANUARY 2019–OCTOBER 2022 252
11 COMPANY PROFILES 253
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 253
11.1.1 FRESENIUS 253
TABLE 214 FRESENIUS: BUSINESS OVERVIEW 253
FIGURE 42 FRESENIUS: COMPANY SNAPSHOT (2021) 254
TABLE 215 FRESENIUS: EXCHANGE RATES UTILIZED FOR CONVERSION OF EUR TO USD 254
TABLE 216 FRESENIUS: PRODUCT LAUNCHES 255
TABLE 217 FRESENIUS: DEALS 256
TABLE 218 FRESENIUS: OTHER DEVELOPMENTS 256
11.1.2 LINDE 258
TABLE 219 LINDE: BUSINESS OVERVIEW 258
FIGURE 43 LINDE: COMPANY SNAPSHOT (2021) 259
11.1.3 F. HOFFMANN-LA ROCHE 261
TABLE 220 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 261
FIGURE 44 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 262
TABLE 221 F. HOFFMANN-LA ROCHE: EXCHANGE RATES UTILIZED
FOR CONVERSION OF CHF TO USD 262
TABLE 222 F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES & APPROVALS 263
TABLE 223 F. HOFFMANN-LA ROCHE: DEALS 264
11.1.4 A&D COMPANY 265
TABLE 224 A&D COMPANY: BUSINESS OVERVIEW 265
FIGURE 45 A&D COMPANY: COMPANY SNAPSHOT (2022) 266
TABLE 225 A&D COMPANY: PRODUCT LAUNCHES 267
11.1.5 INVACARE CORPORATION 269
TABLE 226 INVACARE CORPORATION: BUSINESS OVERVIEW 269
FIGURE 46 INVACARE CORPORATION: COMPANY SNAPSHOT (2021) 270
TABLE 227 INVACARE CORPORATION: PRODUCT LAUNCHES 272
11.1.6 ABBOTT 274
TABLE 228 ABBOTT: BUSINESS OVERVIEW 274
FIGURE 47 ABBOTT: COMPANY SNAPSHOT (2021) 275
TABLE 229 ABBOTT: PRODUCT LAUNCHES AND PRODUCT APPROVALS 276
TABLE 230 ABBOTT: DEALS 277
11.1.7 AMEDISYS 278
TABLE 231 AMEDISYS: BUSINESS OVERVIEW 278
FIGURE 48 AMEDISYS: COMPANY SNAPSHOT (2021) 278
TABLE 232 AMEDISYS: DEALS 280
11.1.8 RESMED 282
TABLE 233 RESMED: BUSINESS OVERVIEW 282
FIGURE 49 RESMED: COMPANY SNAPSHOT (2022) 283
TABLE 234 RESMED: DEALS 285
11.1.9 LHC GROUP 286
TABLE 235 LHC GROUP: BUSINESS OVERVIEW 286
FIGURE 50 LHC GROUP: COMPANY SNAPSHOT (2021) 286
TABLE 236 LHC GROUP: DEALS 288
11.1.10 OMRON CORPORATION 291
TABLE 237 OMRON CORPORATION: BUSINESS OVERVIEW 291
FIGURE 51 OMRON CORPORATION: COMPANY SNAPSHOT (2022) 292
TABLE 238 OMRON CORPORATION: EXCHANGE RATES UTILIZED
FOR CONVERSION OF YEN TO USD 292
TABLE 239 OMRON CORPORATION: DEALS 295
11.1.11 KONINKLIJKE PHILIPS 296
TABLE 240 KONINKLIJKE PHILIPS: BUSINESS OVERVIEW 296
FIGURE 52 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2021) 297
TABLE 241 KONINKLIJKE PHILIPS: EXCHANGE RATES UTILIZED
FOR CONVERSION OF EUR TO USD 297
TABLE 242 KONINKLIJKE PHILIPS: PRODUCT/SERVICE LAUNCHES AND APPROVALS 299
TABLE 243 KONINKLIJKE PHILIPS: DEALS 300
11.1.12 GE HEALTHCARE 301
TABLE 244 GE HEALTHCARE: BUSINESS OVERVIEW 301
FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 302
TABLE 245 GE HEALTHCARE: DEALS 304
11.2 OTHER PLAYERS 305
11.2.1 BAYADA HOME HEALTH CARE 305
11.2.2 DRIVE DEVILBISS HEALTHCARE LIMITED 306
11.2.3 HAMILTON MEDICAL 307
11.2.4 SUNRISE MEDICAL 308
11.2.5 ROMA MEDICAL 310
11.2.6 CAREMAX REHABILITATION EQUIPMENT 312
11.2.7 VITALOGRAPH 313
11.2.8 ADVITA PFLEGEDIENST 314
11.2.9 RENAFAN GMBH 315
11.2.10 ADMR 315
11.2.11 APEX MEDICAL CORP. 316
11.2.12 CONTEC MEDICAL SYSTEMS 317
11.2.13 LÖWENSTEIN MEDICAL TECHNOLOGY 318
11.2.14 B. BRAUN MELSUNGEN AG 319
11.2.15 BAXTER INTERNATIONAL 320
11.2.16 ALLIED HEALTHCARE PRODUCTS 320
11.2.17 MEDLINE INDUSTRIES 321
11.2.18 ADVIN HEALTH CARE 322
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 323
12.1 DISCUSSION GUIDE 323
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 328
12.3 CUSTOMIZATION OPTIONS 330
12.4 RELATED REPORTS 330
12.5 AUTHOR DETAILS 332
